Justin B. Klee

Business address
C/O Amylyx Pharmaceuticals, Inc., 43 Thorndike Street, Cambridge, MA, 02141
Top holdings (ownership)
AMLX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Justin B. Klee has filed 19 SEC EDGAR filings since 06 Jan 2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 02 Oct 2025 30 Sep 2025 001-41199
4 Open Document Open Filing 4 02 Apr 2025 31 Mar 2025 001-41199
4 Open Document Open Filing 4 10 Mar 2025 06 Mar 2025 001-41199
4 Open Document Open Filing 4 05 Mar 2025 03 Mar 2025 001-41199
4 Open Document Open Filing 4 06 Feb 2025 05 Feb 2025 001-41199
4 Open Document Open Filing 4 05 Feb 2025 03 Feb 2025 001-41199
4 Open Document Open Filing 4 08 Jan 2025 06 Jan 2025 001-41199
4 Open Document Open Filing 4 06 Nov 2024 04 Nov 2024 001-41199
4 Open Document Open Filing 4 02 Oct 2024 30 Sep 2024 001-41199
4 Open Document Open Filing 4 18 Apr 2024 16 Apr 2024 001-41199
4 Open Document Open Filing 4 07 Mar 2024 05 Mar 2024 001-41199
4 Open Document Open Filing 4 28 Feb 2024 26 Feb 2024 001-41199
4 Open Document Open Filing 4 11 Jan 2024 09 Jan 2024 001-41199
4 Open Document Open Filing FORM 4 SUBMISSION 20 Mar 2023 16 Mar 2023 001-41199
144 Open Document Open Filing 16 Mar 2023
4 Open Document Open Filing FORM 4 SUBMISSION 10 Jan 2023 06 Jan 2023 001-41199
4 Open Document Open Filing FORM 4 SUBMISSION 06 May 2022 05 May 2022 001-41199
4 Open Document Open Filing FORM 4 SUBMISSION 10 Jan 2022 06 Jan 2022 001-41199
3 Open Document Open Filing FORM 3 SUBMISSION 06 Jan 2022 06 Jan 2022 001-41199